{"timestamp": 1771604708.7998295, "value": {"ticker": "NXL", "company_name": "Nexalin Technology, Inc.", "short_name": "Nexalin Technology, Inc.", "sector": "Healthcare", "industry": "Medical Devices", "country": "United States", "market_cap": 9325970, "float_shares": 15931554, "shares_outstanding": 18651939, "short_ratio": 1.08, "short_percent_of_float": 0.0091, "shares_short": 147226, "shares_short_prior": 45120, "insider_percent_held": 0.1378, "institution_percent_held": 0.064109996, "total_cash": 4352677, "total_debt": 0, "total_revenue": 156931, "revenue_growth": -0.496, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.69515, "operating_margins": -129.24298, "debt_to_equity": 0, "current_ratio": 13.474, "book_value": 0.262, "price_to_book": 1.908397, "operating_cashflow": -4944112, "free_cashflow": -1841967, "price": 0.5, "52w_high": 3.54, "52w_low": 0.401, "avg_volume": 270135, "avg_volume_10d": 877880, "full_time_employees": 6, "audit_risk": 0, "overall_risk": 0}}